---
document_datetime: 2025-11-27 09:35:27
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/celdoxome-pegylated-liposomal-epar-all-authorised-presentations_en.pdf
document_name: celdoxome-pegylated-liposomal-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9575652
conversion_datetime: 2025-12-15 06:16:34.09463
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name               | Strength   | Pharmaceutical Form                        | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------------------|------------|--------------------------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/22/1666/001 | Celdoxome pegylated liposomal | 2 mg/ml    | Concentrate for dispersion for infusion    | Intravenous use           | vial (glass)          | 10 ml authorised          | 1 vial      |
| EU/1/22/1666/002 | Celdoxome pegylated liposomal | 2 mg/ml    | Concentrate for dispersion for infusion    | Intravenous use           | vial (glass)          | 10 ml                     | 10 vials    |
| EU/1/22/1666/003 | Celdoxome pegylated liposomal | 2 mg/ml    | Concentrate for dispersion for infusion    | Intravenous use           | vial (glass)          | 25 ml                     | 1 vial      |
| EU/1/22/1666/004 | Celdoxome pegylated liposomal | 2 mg/ml    | Concentrate for dispersion for infusion no | Intravenous use longer    | vial (glass)          | 25 ml                     | 10 vials    |